LILY CHENG to Aged, 80 and over
This is a "connection" page, showing publications LILY CHENG has written about Aged, 80 and over.
Connection Strength
0.025
-
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma. Leuk Lymphoma. 2024 12; 65(12):1789-1800.
Score: 0.025